- Iryss is a startup aiming to reduce financial stress for people with chronic illnesses by offering a tailored financial planning platform.
- The platform uses disease-specific financial models that allow users to predict the impact of their diagnosis on their income, expenses, and assets.
- The segment of people diagnosed with chronic illnesses is estimated to be around 3.2 million per year, in a financial planning and advice market worth $57 billion.
- Iryss has its roots in the Founders Institute and is based in Rochester, New York.
- The success of Iryss could revolutionize financial planning for individuals with long-term health conditions.
The realm of Fintech has made significant strides in providing solutions for a host of financial planning needs. However, there has been a void with respect to addressing the unique challenges faced by individuals diagnosed with chronic illnesses. Iryss aims to plug this gap by creating a financial planning platform specifically designed to reduce the financial stress of navigating through these health conditions.
Based in Rochester, New York, Iryss is positioning itself at the forefront of the fusion between healthcare and financial planning. A debutante from the Founders Institute, Iryss identifies the extensive potential in the $57 billion financial planning and advice market.
What sets Iryss apart is its disease-specific financial planning model. The platform employs these specialized models to predict how a chronic illness diagnosis will impact a person’s income, expenditure, and assets over the long term. This form of personalized financial planning paves the way for more informed decisions, creating the roadmap to a more financially secure future despite health complications.
Beyond this, Iryss provides its users with tools and services to meet their current obligations, whilst simultaneously planning for their future. This simultaneous approach enables its users to balance their immediate financial needs with future financial aspirations, all whilst navigating their health landscape.
Looking to the future, if Iryss manages to deliver on its promise, it can revolutionize the way individuals diagnosed with chronic conditions plan their finances. The fusion of fintech with health-care-specific-data can help in predicting specific financial concerns, aiding in more comprehensive, personalized financial planning.
Ready to Promote Your Brand with Finance Magazine?
Looking to reach a targeted audience of finance professionals and decision-makers? Finance Magazine offers sponsored article opportunities and partnerships to help you showcase your brand and drive sales. Learn more about our advertising options and reach out to us today! Click here to discuss sponsored articles and partnerships.
Maximize your brand visibility and engage with a highly engaged finance audience. Contact us at [email protected] to get started. Let Finance Magazine be your platform for success!